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S
uccessful bloodfeeding by female mosquitoes is a key event in the transmission of a variety of viral and parasitic diseases, including malaria and dengue fever. The salivary secretion injected into the host at the time of feeding is rich in pharmacologically active substances that facilitate the uptake of blood by counteracting host hemostatic, inflammatory, and immunological defenses (1, 2) . With the onset of feeding, biogenic amines are rapidly released into the blood and skin from platelets, mast cells, and sympathetic neurons, while eicosanoids are secreted by mast cells (3) (4) (5) (6) . These molecules mediate a variety of early responses to wounding including vasoconstriction, platelet activation, swelling, itching, and pain. Prevention of these processes is particularly important for avoiding host defensive behaviors that may interrupt feeding. One mechanism for the neutralization of small-molecule effectors of inflammation is to rapidly bind them with abundant proteins having high-affinity ligand-binding sites (3, 4, 6, 7) . Bloodfeeding ticks and triatomine bugs produce proteins belonging to the lipocalin family that act in this manner (3, 6, 7) . More recently, the D7 family of proteins from mosquitoes has been found to perform essentially the same function (4, 8, 9) .
The salivary D7 proteins in Aedes spp. and the D7-related (D7R) proteins in Anopheles spp. show a distant relationship with the arthropod odorant-binding protein (OBP) superfamily (4, (10) (11) (12) (13) . D7 variants having one or two OBP domains are among the most abundant proteins in the salivas of culicine (Aedes and Culex spp.) and anopheline mosquitoes (14) (15) (16) . Proteins having a biogenic amine-binding function in Aedes spp. contain two OBP domains, whereas the anopheline forms have a single OBP domain. Here, we describe the structure and function of AeD7, the two-domain D7 protein from Aedes aegypti saliva. We find that in accordance with its two-domain structure, the protein is bifunctional and acts to neutralize two different classes of inflammatory mediators. It is the C-terminal domain that exhibits the described biogenic aminebinding function, whereas the N-terminal domain is found to have a novel leukotriene-binding activity. The binding of biogenic amines with the C-terminal domain is shown to involve extensive conformational changes in the protein that act to stabilize the bound ligand while at the same time increasing the structural diversity of mediators that can be accommodated at the ligandbinding site.
Results
Overall Structure of AeD7. The structure of AeD7 was determined by using single anomalous dispersion methods with a crystal derivatized by briefly soaking in cryoprotectant containing potassium bromide [supporting information (SI) Table S1 ]. As suggested from sequence comparisons, AeD7 contains two OBP-like domains that are distantly similar to one another in amino acid sequence (15% overall identity). In the ligand-free structure, each domain is made up of seven ␣-helices with the N-terminal domain (residues 1-150) being stabilized by two disulfide bonds and the C-terminal domain (residues 151-303) by three disulfide bonds (Fig. 1) . Disulfide bonds of the N-terminal domain link Cys-16 of helix B with Cys-53 of helix C, and Cys-49 of helix C with Cys-106 of helix F. In the C-terminal domain disulfide bonds link Cys-157 of helix A 2 with Cys-192 of helix C 2 , Cys-232 of helix E 2 with Cys-250 of helix F 2 , and Cys-173 of helix B 2 with Cys-301 near the C terminus. Of the five disulfides, four are found in other members of the arthropod OBP protein family. The disulfide bond that links helix B 2 with the C terminus is found only in the mosquito AeD7 group (4, 8) .
The two domains of AeD7 are connected by a nine-residue coil and contact each other via an interface comprising parts of helix A from the N-terminal domain and portions of helices C 2 , D 2 , and E 2 from the C-terminal domain (Fig. 1) . The interface buries 1,770 Å 2 of the molecular surface and is stabilized by numerous salt bridge and cation-interactions (Fig. S1) . Superposition of helices A-F (rmsd 2.3 Å for 57 C ␣ positions) in the N-and C-terminal domains shows that a kink in helix F of the N-terminal domain corresponds to a tight turn connecting helices F 2 and G 2 in the C-terminal domain. The C-terminal domain is similar in sequence and structure to the single domain biogenic amine-binding D7R proteins from Anopheles spp., suggesting that it is the biogenic aminebinding domain. The putative ligand-binding pocket of the Nterminal domain is substantially different in structure, suggesting a distinct ligand-binding function. binding pocket bounded by helices A-C and F that leads from the surface of the protein to the interior (Fig. 2) . The channel is lined primarily, but not exclusively, with hydrophobic residues including Phe-13, Trp-37, Val-54, and Leu-55. The apparent entry point to the channel is located at the center of a positively charged surface of the N-terminal domain bounded by helices A, B, and G ( Figs. 1  and 3 ). Based on the architecture and relatively hydrophobic nature of this putative ligand-binding site, we hypothesized that it may accommodate bioactive lipid mediators involved in host inflammatory responses to mosquito feeding.
Binding Specificity of the N-Terminal Domain. A panel of proinflammatory and prohemostatic lipid compounds was tested in binding assays using isothermal titration calorimetry (ITC). These included a number of leukotrienes (LTs; Fig. 4) , and the platelet activators arachidonic acid (Fig. 4) , platelet-activating factor (PAF), and the thromboxane A 2 analog U46619.
The highest binding affinities were observed for LTs, particularly the cysteinyl LTs (cysLTs) LTC 4 , LTD 4 , and LTE 4 , which are released by mast cells in the skin where they serve as important mediators of inflammation and vascular tone [ Table 1 and Figs. S2 and S3 (17) ]. These compounds consist of an eicosenoid fatty acid conjugated with glutathione, or a glutathione fragment, via a thioether linkage at C6 of the lipid chain (Fig. 4) . LTC 4 is secreted from cells and then metabolized to LTD 4 and LTE 4 by successive cleavages of the glutathione group (Fig. 4) . The similar binding affinities for all three cysLTs suggest that the lipid chain is the primary contact point with the protein and that with the possible exception of the cysteinyl group, the peptide portion of the molecule plays only a minor role in binding. The binding affinity for LTB 4 was 2-to 3-fold lower than for the cysLTs (Table 1 ). This compound is structurally related to the cysLTs but has no conjugated peptide, is hydroxylated at both C5 and C12 of the lipid chain, and has a 6Z, 8E, 10E, 14Z pattern of unsaturations rather than the 7E, 9E, 11Z, 14Z pattern seen with the cysLTs (Fig. 4) . As would be expected from a reaction mechanism dominated by the hydrophobic effect, the temperature dependence of ⌬H for cysLT binding was strongly negative, producing values for the change in heat capacity (⌬Cp) of Ϸ1 kcal mol Ϫ1 K Ϫ1 (Table 1 and Fig. S3 ). Of the other lipids tested, only the phosphatidylcholine derivative PAF showed detectable binding, but the affinity was Ϸ200-fold lower than observed for the cysLTs ( Table 1 ), suggesting that the interaction is probably not physiologically relevant (Table 1) . Arachidonic acid and U46619 showed no detectable binding, further indicating that the primary function of the N-terminal domain is to limit inflammatory responses via LT binding rather than inhibiting platelet activation by binding other mediators.
The lack of discrimination between the different cysLTs tested in binding experiments suggested that the lipid chain is inserted into the narrow hydrophobic channel of the N-terminal domain whereas the glutathione moiety of the cysLTs and the charged head group of PAF lie outside of the channel. A positional isomer of LTC 4 , 14,15-LTC 4 , has the glutathione conjugated at C14 of the lipid chain and a hydroxyl group at C15, rather than having conjugation at C6 and hydroxylation at C5 (Fig. 4) . This compound showed no detectable binding, indicating that a bulky group near the -end of the lipid can interfere with ligand association and that it is this end of the molecule that inserts into the binding pocket. Furthermore, the importance of the 5-hydroxyl group was demonstrated by the diminished binding exhibited by (Z)-11-eicosenoic acid (Table 1) . Although this compound otherwise resembles the lipid portion of the cysLTs in shape and polarity, it lacks a 5-hydroxyl and exhibits a binding affinity Ϸ15-fold lower than the cysLTs ( Table 1) .
Structure of the AeD7-LTE4 Complex. The structure of the complex between AeD7 and LTE 4 was determined after soaking a crystal in 250 M LTE 4 added to the crystallization drop for 2 days before freezing (Table S1 ). Continuous electron density corresponding to the lipid chain of the ligand (F o Ϫ F c omit map contoured at 2.5 , with phases calculated from a ligand-free AeD7 model) was observed in the binding pocket of the N-terminal domain. A molecule of 5(S)-hydroxy-(E,E,Z,Z)-7,9,11,14-eicosatetraenoic acid was built into the electron density, and the model of the complex was refined (Fig. 2) . It is clear from the refined structure that the fatty acyl portion of the molecule is inserted into the binding channel with its -end occupying the interior-most point. The lipid chain could be traced from its -end to the carboxyl group that forms hydrogen bonds with Lys-149 and Thr-135 (Fig. 2) . The hydroxyl substituent at C5 is also visible, forming hydrogen bonds with the side chain of Trp-37 and the carbonyl oxygen of Gly-130, but the cysteinyl group is not well ordered, and only unconnected fragments of positive electron density are visible at its likely location in the 2F o Ϫ F c map.
Structure of the C-Terminal Domain. The C-terminal domain of AeD7 is similar in its sequence and function to the single-domain D7R group of proteins found in Anopheles gambiae (8) . Full-length AeD7 has been shown to bind biogenic amines in a manner similar to the D7R proteins (4). The stoichiometries of both biogenic amine (4) and LT binding (Table 1) , as measured by ITC, are near unity, indicating that a single binding site for each type of ligand is present in each AeD7 molecule. LTD 4 was found to bind normally in the presence of a saturating (20 M) concentration of serotonin ( Table  1 ), confirming that cysLTs bind only to the N-terminal domain, biogenic amines only to the C-terminal domain, and that binding of biogenic amines does not affect the binding of LTs.
As expected from the similarity of their sequences, the structure of the C-terminal domain of ligand-free AeD7 is similar to the reported structure of D7R4 from A. gambiae (8) . Surprisingly, the C-terminal eighth helix (H) seen in D7R4 is missing in AeD7 (Fig.  5) . Instead, this part of the protein forms a coil extending from residue 280 to 293 in which residues 290-293 are poorly ordered, followed by an ordered region containing a type IЈ ␤-turn (18), extending from Met-294 to Cys-301 ( Fig. 5 and Fig. S4 ). The observed conformation exposes a large, negatively charged surface that corresponds to the interior of the ligand-binding pocket of D7R4 (Fig. 3) .
Conformational Change Stabilizes the Norepinephrine Complex. The structure of the AeD7-norepinephrine complex was determined after soaking a crystal in cryopreservative containing 1 mM norepinephrine before freezing (Table S1 ). Upon binding of the ligand, the C-terminal portion of the biogenic amine-binding domain is ordered into an ␣-helix (H 2 ) extending from Ser-285 to Cys-301 and corresponding in its position to the eighth ␣-helix (helix H) of D7R4 (Figs. 5 and 6A and S4). The formation of helix H 2 is accompanied by rotations of the side chains of Arg-176 and Glu-268 that act as a gate, trapping the bound ligand and further closing the entry path ( Fig. 5 and Fig. S5 ). In its new position, the side chain of Glu-268 forms a hydrogen bond with the amino group of norepinephrine ( Fig. 7A and Fig. S6 ). Previous studies in which the corresponding residue in D7R4 (Glu-114) was mutated show that this electrostatic interaction is important in stabilizing the bound ligand (8). The ordering of helix H 2 also brings the side chain of Asp-297 into position to hydrogen bond with the amino group of the bound ligand through an intervening water molecule (Fig. 7A ). An analogous interaction, involving Asp-139, is also observed in the D7R4 complex with serotonin [ Fig. 7C (8) ]. When the ligand-bound AeD7 C-terminal domain and the D7R4-serotonin complex are superimposed, the binding pocket structures are found to be nearly identical ( Fig. 7 A and C) .
Discussion
Inflammatory Mediators and Mosquito Feeding. In the short time needed for a female mosquito to obtain a blood meal, swelling, itching, and pain responses are initiated in the host. Presumably, the antiinflammatory agents contained in saliva are aimed at limiting these early responses. As a result of biting, biogenic amines are released by platelets and mast cells in the skin and blood where they elicit pain responses (19) (20) (21) , which in turn trigger defensive behaviors by the host. Additionally, norepinephrine and serotonin stimulate adrenergic and serotonin receptors in the vasculature, resulting in constriction of blood vessels and limitation of the flow of blood to the mouthparts. In a parallel fashion, bioactive lipids, most notably the cysLTs, are released by mast cells and induce swelling, erythema, pain, and itching that begin almost immediately (22, 23) . In some tissues, these compounds also induce vasoconstriction (22) . Again, limitation or delay of these effects may be critical to ensuring an uninterrupted period of feeding. Any disruption of feeding by a female mosquito would have the obvious consequence of reducing the efficiency of virus or parasite transmission, which underscores the importance of understanding how mosquitoes delay the host response. AeD7 is tailored to bind a number of biologically important molecules while maintaining a high degree of selectivity. The N-terminal domain is specific for bioactive lipids, particularly the cysLTs, whereas the C-terminal domain binds only biogenic amines. The N-terminal domain binding pocket is a mainly hydrophobic channel leading to the protein interior (Fig. 2) , whereas the C-terminal pocket contains polar and charged residues that form electrostatic and hydrogen-bonding interactions with the ligand (Fig. 7A and Fig. S6 ). The electrostatic surfaces presented at each binding site are consistent with the type of ligand bound (Fig. 3) . The N-terminal binding pocket is surrounded by basic residues that would interact favorably with the carboxyl groups of the eicosenoid and peptide portions of the cysLTs (Fig. 3) . Likewise, the binding site for the cationic biogenic amines is seen as a negatively charged patch on the surface of the C-terminal domain (Fig. 3) .
Significance of CysLT Binding by the N-Terminal Domain. The similar affinities observed for LTC 4 , LTD 4 , and LTE 4 suggest that removal of all of these lipid species is necessary, or at least beneficial, to a feeding mosquito. Although LTC 4 is the primary mast cell product, the three cysLTs show similar activity in inducing erythema and wheal formation when injected into the skin (23) . This being the case, a binding site that specifically recognizes the lipid features common to all cysLTs, without distinguishing differences in the peptide portion of the molecule, may have the most beneficial overall antiinflammatory effect.
Recognition of the lipid portion of the cysLT structure by AeD7 is based mainly on the presence of the carboxyl group, a hydroxyl group at C5, and a specific arrangement and geometry of the unsaturations. With its all-cis configuration, arachidonic acid does not take on the approximately linear conformation of the C1-C15 portion of the lipid chain that is observed in the structure of the AeD7-LTE 4 complex. This, along with the lack of hydroxylation, would explain the absence of detectable binding by AeD7. LTB 4 differs from the cysLTs in both hydroxylation and unsaturation pattern. It consequently binds less tightly to AeD7 than do the cysLTs and would be removed less efficiently from the area of the bite.
Conformational Change in the C-Terminal Domain and Ligand Selectivity of D7 Proteins. The conformational change of AeD7 appears to act as a stabilizing mechanism for bound biogenic amines and may play a role in determining the binding specificity of the protein. D7R4, the only other member of the group to be structurally characterized, does not undergo a conformational change and remains in the closed conformation even in the absence of ligands. Nevertheless, it binds serotonin with an affinity equal to AeD7, whereas AeD7 binds norepinephrine as tightly as serotonin and Ϸ600-fold more tightly than does D7R4 (4). Conformational changes resulting in burial of the bound ligand may act to improve the binding of norepinephrine, which differs from serotonin in having a hydroxyl group at the C␤ position of the alkyl side chain. Ligand-free AeD7 presents a broad, negatively charged surface lying between helix A 2 , helix G 2 , and the C-terminal coil region that would be attractive to the cationic biogenic amines (Figs. 3A, 5 , and 6B). The structures described here suggest that Arg-176, Glu-268, and helix H 2 fold around the ligand by an induced-fit type mechanism, possibly allowing the accommodation of a greater diversity of ligand structures and conformations. In D7R4, helix H is present in both the ligand-bound and -free forms and blocks the entry path seen in AeD7. In this case, the ligand appears to enter the more rigid structure through a channel at a negatively charged surface lying between helices B, G, and H (Figs. 3C , 5B, and 6B).
The binding mode of norepinephrine in its AeD7 and D7R4 complexes is clearly different and consistent with the observed differences in binding affinity. In the D7R4 complex, the secondary hydroxyl group at C ␤ of the ligand forms hydrogen bonds with the side chains of Asp-111 and Glu-114. In the AeD7-norepinephrine complex, the side chain of the ligand is rotated relative to its position in D7R4, allowing the amino group to form hydrogen bonds with Asp-265 and Glu-268 (equivalent to Asp-111 and Glu-114 in D7R4) and the secondary hydroxyl to hydrogen bond with the carbonyl group of Arg-176 (Fig. 7A) . As situated in D7R4, norepinephrine is not in position to form hydrogen bonds between its phenolic hydroxyl groups and the protein (Fig. 7 A and B and Fig.  S6 ). In the AeD7-norepinephrine complex, the phenolic hydroxyls of the ligand are in position to form hydrogen bonds with the side chains of Glu-158 and His-189 ( Fig. 7 A and B) . In the AeD7-binding mode, the ligand forms seven hydrogen bonds, whereas only four are observed in the D7R4-norepinephrine complex. The AeD7 arrangement more closely resembles the high-affinity binding mode seen in the D7R4 complex with serotonin ( Fig. 7C) (4) . It appears that AeD7 is able to stabilize bound norepinephrine by accommodating a different conformation of the bound ligand that allows the amino group to form salt bridges or hydrogen bonds with Asp-265 and Glu-268.
Relationships of D7 Proteins from Bloodfeeding Diptera. Salivary proteins of bloodfeeding arthropods are commonly encoded by clusters of related genes having demonstrable functional differences. In Anopheles mosquitoes, the biogenic amine-binding function of AeD7 has been taken over by the D7R proteins that apparently resulted from duplication of the C-terminal domain of a two-domain protein similar to AeD7 (4). The two-domain D7 forms present in Anopheles (Fig. S7) show a high degree of conservation of the N-terminal domain, suggesting that they also bind LTs. The C-terminal domains of the Anopheles forms differ from AeD7 in a number of essential binding site residues, suggesting that they do not bind biogenic amines (Fig. S7) and may perform a different function.
Experimental Procedures
Materials. L-(Ϫ)-Norepinephrine-(ϩ)-bitartrate salt monohydrate (Ͼ97% purity), (Z)-11-eicosenoic acid (99% purity), and PAF (Ͼ97% purity) were obtained from Sigma-Aldrich. LTs (Ͼ97% purity) B 4, C4, D4, and E4 and arachidonic acid (Ͼ 97% purity) were obtained from Cayman Chemical. U46619 (100% purity) was from Calbiochem.
Protein Production. AeD7 protein was produced in HEK-293 cells by using methods described in ref. 4 . Processing of the signal peptide leaves an additional seven vector-encoded residues at the N terminus of the protein that were disordered in the crystal and not modeled.
Crystallization and Data Collection. AeD7 was crystallized by using the hangingdrop vapor diffusion method from 16 to 20% PEG 6000, 100 mM Tris⅐HCl (pH 7.5). The crystals were frozen for data collection in the crystallization buffer described above, containing 15% glycerol. A potassium bromide derivative was obtained by soaking crystals for 30 -60 s in cryoprotectant containing 1 M KBr (24) . Norepinephrine was added to the crystal by soaking in cryoprotectant containing 1 mM ligand for 10 -15 min. LTE 4 dissolved in crystallization buffer solution was added to a crystallization drop to a concentration of 250 M. After 2 days, the crystals were frozen by using the cryoprotectant described above.
Data collection was performed at beamlines 19-ID and 19-BM of the Structural Biology Center, Advanced Photon Source (APS), Argonne National Laboratory, or beamline 22-BM of the South East Regional Collaborative Access Team (SER-CAT), APS, Argonne National Laboratory. The crystals belong to the space group P2 1 and contain one monomer per asymmetric unit (Table S1 ). Four datasets were collected from a potassium bromide-soaked, unliganded crystal (1.70-Å resolution), an unliganded crystal (1.30-Å resolution), a norepinephrine-soaked crystal (1.75-Å resolution), and a LTE 4-soaked crystal (1.80-Å resolution).
Structure Solution and Refinement. The structure of AeD7 was determined by using single anomalous dispersion methods after data collection near the bromine absorption edge (24) . The data were indexed, integrated, and scaled using HKL3000 (25) . Initial phases were also obtained by using the HKL3000 package that combines SHELXD-E, MLPHARE, and DM for the location of bromine sites, solvent flattening, phasing, and density modification (25) (26) (27) (28) (29) (30) . From the experimental map, a large part of the structure could be built by using ARP-WARP (31) . The model was completed by manual building in Coot (32) and refined by using REFMAC (26) . In some cases a TLS model was applied for refinement by using a single TLS group (26) . The structures of the unliganded protein in the presence and absence of potassium bromide were nearly identical [rmsd for all C ␣ positions ϭ 0.24 Å as measured by using LSQMAN (33) ]. The initial model for 5(S)-hydroxy-(E,E,Z,Z)-7,9,11,14-eicosatetraenoic acid was built by using SYBYL (Tripos).
ITC. Binding measurements were made by using ITC on a Microcal VP-ITC microcalorimeter. Lipid ligand compounds dissolved in ethanol or chloroform were prepared by evaporating the solvent to dryness under a stream of nitrogen. The lipid ligand candidates were then dissolved in 20 mM Tris⅐HCl (pH 8.0), 0.15 M NaCl at concentrations beneath the critical micellar concentration (cmc) of 73 M reported for arachidonic acid (34) . LTB 4, C4, D4, and E4 are reported to be soluble at concentrations above 100 M by the producer, Cayman Chemical. In the case of PAF, the final concentration of ligand in the calorimeter cell was Ϸ35 M, which is close to the reported cmc of 36 M in buffer containing 85 mM salt (35) . The observation of binding stoichiometries near 1:1 for all ligands in the ITC experiments suggests that no fraction of the lipid in solution was unavailable for binding. All lipid solutions were sonicated for 10 min before use to ensure dissolution. Experiments were run at 30°C, and 10-L injections of either lipid or biogenic amine were made for data collection. For heat capacity measurements of the cysLTs, data were also collected at three additional temperatures. After integration, the heats were converted to enthalpies by using the Microcal Origin software, and the heat of dilution, as estimated from postsaturation heats (Fig.  S3) , was subtracted from each point. Thermodynamic parameters were obtained by fitting the values to a single site binding model in the Microcal Origin software package.
